Lay opinion vs evidence: Stuhlprobe Genetik

The question of stool sample genetics merges two distinct concepts: classical stool diagnostics (e.g., occult blood, inflammation markers like calprotectin) and genetic analyses from stool (e.g., microbiome DNA or human DNA from shed cells). Lay opinions often attribute high predictive power to such tests – from cancer screening to diet optimization. The evidence is nuanced: For colorectal cancer screening (fecal immunochemical test, FIT), there is strong clinical evidence (human-strong). For microbiome genetics (16S rRNA or shotgun sequencing), evidence is moderate to mechanistic: associations with diseases exist, but causal individual predictions are rarely possible. Human DNA from stool (e.g., for inherited mutations) is methodologically challenging and not validated for home tests. Many direct-to-consumer companies overstate clinical relevance. Caveat: stool genetics does not replace medical diagnostics; results are often exploratory and lack standardization.